We're aware of a global phishing scam impersonating employees via email, WhatsApp, and Telegram, but no PageGroup systems have been breached. Find out how to protect yourself
Browse our jobs and apply for your next role.
Reach out to us or discover some great insights that could help you fill your next vacancy.
PageGroup changes lives for people through creating opportunity to reach potential.
We find the best talent for our clients and match candidates to their ideal jobs.
Our technology is revolutionising the treatment of HPV infections globally, and is widely used in Dermatology, Podiatry and Oncology, with a number of disruptive applications under development in the fields of Cardiology and Gynaecology.
The company was started in 2007 by our joint co-founders (current Chief Executive Officer and Chief Technology Officer) and inventors behind the technology. They form part of our highly experienced management team with over 50 years of experience in this field.
You can now find our medical devices in 1000s of clinics and hospitals across the UK, the US, Canada, and Australia. We are just at the start of our journey and you will be joining our team at a key phase in our growth, underpinned by 3 primary goals:
The next five years will be exciting, join us for it!
Working at Emblation is "rewarding", "fast-paced", "challenging", and "exciting" according to our employees - as we invest in the growth of our business, we are committed to investing in our culture at the same rate.
When you join us your line manager will support your career development ambitions and proactively work with you to identify training and development opportunities to support your personal growth
The three pillars of our organisation are people, product, and partners. We are an innovation-led company, seeking positive, hard-working, creative, and loyal new additions.
Our employees are motivated by a desire to help patients, create better technology, and continuously improve their skills to help their teams achieve their collective goals.
Gary Beale is Co-founder and Chief Executive Officer of Emblation. Since forming the organisation in 2008, Gary is responsible for the continual expansion of the business, including lucrative commercial partnerships with a number of global organisations and Emblation’s programme of research and development.
Eamon McErlean is our Co-founder and Chief Technology Officer. Since co-founding the organisation in 2008, Eamon is responsible for generating intellectual property and leading the technology and engineering strategy. He has published in international peer reviewed journals, and has authored close to 165 patents cases.
Joining the company in 2011 as the 5th employee at a pre-commercialisation stage, Jonathan has led 4 successful product launches in the UK, Canada, Australia, and the US, in addition to growing the OEM business and developing the commercial function.
Jonathan is a Vice Chair of the ABHI's Scottish working group (Association of British HealthTech Industries) and has recently been invited to join the ILG Internationalisation sub-group.
Fraser joined the company in February 2021 with the aim of establishing a Finance and Support function to partner the business as it expands commercial activities in many new territories.
Fraser is responsible for creating value through the understanding of the Emblation's financial performance, as well as the identification and management of business opportunities and risk.
Fraser brings a wealth of commercial finance and operational experience from his previous roles with Edinburgh Airport, Diageo and RBS.
Mairi joined Emblation in 2018 and is responsible for regulatory and quality system compliance in support of global market requirements.
She has more than 25 years’ experience in the medical devices sector, working mainly in senior quality and regulatory management roles.
